ARBUTUS BIOPHARMA CORP (ABUS) Stock Income Statement
USA - NASDAQ:ABUS - CA03879J1003 - Common Stock
4.5644 USD
+0.04 (+0.98%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 15.42M | 6.17M | 18.14M | 39.02M | 10.99M | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 58.74M | 78.77M | 96.24M | 104.48M | 84.51M | |||
| Research and Development | 37.54M | 54.04M | 73.70M | 84.41M | 65.50M | |||
| Selling, General, and Administrative Expenses | 18.41M | 22.11M | 22.48M | 17.83M | 17.14M | |||
| Operating Income | -43.33M | -72.60M | -78.10M | -65.46M | -73.52M | |||
| Interest Income/Expense | 5.33M | 6.40M | 5.25M | 440.00K | -2.73M | |||
| Other Income/Expense | null | null | null | null | null | |||
| Non Recurring Items | -16.26M | -3.72M | null | null | 0 | |||
| Income Before Taxes | -54.25M | -69.92M | -72.85M | -65.01M | -76.25M | |||
| Income Tax | null | 0 | 0 | 4.44M | null | |||
| Net Income | -54.25M | -69.92M | -72.85M | -69.46M | -88.39M | |||
| EBITDA | -42.32M | -71.22M | -76.70M | -64.03M | -71.77M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.2859 | -0.3767 | -0.439 | -0.46 | -0.83 | |||
| Non GAAP EPS | -0.28 | -0.37 | -0.43999999999999995 | -0.47095 | -0.83 | |||
| Statistics | ||||||||
| Profit Margin | -351.92% | -1133.04% | -401.57% | -178.01% | -804.28% | |||
| Operating Profit Margin | -281.05% | -1176.45% | -430.53% | -167.76% | -668.97% | |||
All data in USD